Tracking a patient with no technetium-99m-pyrophosphate myocardial uptake at surgical valve replacement for aortic stenosis
Koji Takahashi
Daisuke Sasaki
Takaaki Iwamura
Shuhei Yamamoto
Mitsuharu Ueda
Nobuhisa Yamamura
Mako Yoshino
Daijiro Enomoto
Hiroe Morioka
Shigeki Uemura
Takafumi Okura
Tomoki Sakaue
Katsuji Inoue
Abstract：Aortic stenosis (AS) is the most common valvular heart disease, with a prevalence of over 4% among octogenarians.[1] The prevalence of autopsy-confirmed wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) increases with age, accounting for 25% of patients aged 85 years and older in Europe and 12% of patients older than 80 years in Japan.
Machine-generated Keywords：
Publication Date：2025-09-30
Online Publishing Date：2025-11-14(First online date of this platform, not the publication date of the document)
Pages：6( 828-833 )